| KALA BIO INC. DL-,001 |
| USA |
| Gesundheit |
| US4831192020 / A3DWPS |
| 27F0 (Frankfurt) / KALA (NASDAQ) |
| FRA:27F0, ETR:27F0, 27F0:GR, NASDAQ:KALA |
| - |
| https://www.kalarx.com/ |
|
Kala Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for eye diseases. Its primary function is to address unmet needs in t..
>Volltext.. |
| 304.97 Mio. EUR |
| 312.57 Mio. EUR |
| - |
| -35.63 Mio. EUR |
| -30.91 Mio. EUR |
| -5.12 EUR |
| 25.83 Mio. EUR |
| 18.19 Mio. EUR |
| -27.63 Mio. EUR |
| 0.65 |
| - |
| 12.72% |
| - |
| - |
| - |
| - |
| KALA BIO |
| 05.03.26 |
|